This week, a top broker named 3 ASX All Ords stocks that could deliver significant upside.
The S&P/ASX All Ords Index (ASX: XAO) has rallied 15% since its April low.
There have been a few standout performers. For example, Pro Medicus Ltd (ASX: PME) has surged 57% since 7 April, while Lovisa Holdings Ltd (ASX: LOV) is up 40% over the same timeframe.
Those who recently invested in the US have enjoyed even greater returns. Since 7 April, the S&P 500 Index (SP: .INX) has risen 19%, with several high-profile companies, such as Nvidia Corp (NASDAQ: NVDA) and Tesla Inc (NASDAQ: TSLA), up more than 50% from their recent low.
As a result, investors may think they've missed out on buying companies with significant upside. However, not all is lost. Broker Macquarie has named 3 ASX All Ords companies which could deliver returns between 30% and 77% from here.
Australian shares have increased at an average compound annual growth rate (CAGR) of 9.1% over the past 30 years, according to Vanguard. Therefore, this would be an excellent outcome.
Monash IVF Group Ltd (ASX: MVF)
The first ASX All Ords company is Monash IVF, which operates 13 permanent clinics across Australia. The company is down 40% for the year to date. Last month, it was heavily sold off due to an incident involving one of its clinics accidentally implanting another woman's embryos into a patient. This debacle attracted significant media attention, which continues to weigh on investor sentiment.
However, Macquarie believes the ASX All Ords stock has been oversold. In a note released this week, Macquarie suggested the company is well placed to benefit from several structural tailwinds. This includes "an increase in average age of new mothers, increased male infertility, increased success rates, and increased use of donor services".
Macquarie has a price target of $1.30 on the company, suggesting a 77% upside from the time of writing.
Vault Minerals Ltd (ASX: VAU)
Vault Minerals is a second stock named with significant upside. In stark contrast to Monash IVF, Vault Minerals has had an outstanding start to 2025, rising 34% for the year to date.
Broker Macquarie tips Vault Minerals shares to continue rising over the next 12 months. In a recent note, the broker cited Vault Minerals' 28 May market announcement regarding its 'King of the Hills' open pit in Western Australia. Pleasingly, the company revealed that the mine has higher reserves and a longer operational life.
The broker has placed a $0.57 price target on the ASX All Ords mining stock. This suggests 30% upside at the time of writing.
Integral Diagnostics Ltd (ASX: IDX)
Integral Diagnostics is the third company named with significant potential upside. The company provides diagnostic imaging services to general practitioners, medical specialists, and allied professionals.
The ASX All Ords healthcare company has also been heavily sold off this year, declining 17% for the year to date. Its share price tumbled 30% in February on its half-year result, but it has rebounded 14% since then.
Macquarie is tipping that better days lie ahead, with a price target of $3.20. The broker expects the ASX All Ords company to "benefit from cost synergies related to the CAJ merger, leading to significant EPS accretion." This price target suggests 30% upside from here at the time of writing.
The post Top broker names 3 ASX All Ords stocks with between 30% and 77% upside appeared first on The Motley Fool Australia.
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa, Nvidia, and Tesla. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Integral Diagnostics, Lovisa, Nvidia, and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2025